NEW YORK, NY / ACCESSWIRE / April 4, 2022 / Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, announces that it is investigating NeoGenomics Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO) for potential violations of the federal securities laws.
On Monday, March 28, 2022, NeoGenomics Inc. Chief Executive Mark Mallon stepped down as the health-testing company revealed that first-quarter financials will miss guidance and rescinded its forecast for the full year, sending shares down more than 20% in after-hours trading.
If you currently own stock or options in NeoGenomics Inc. and suffered a loss, click here to participate.
If you want to receive additional information and protect your investments free of charge, please contact David J. Schwartz using the toll-free number (800) 321-0476 or via email at [email protected].
About the Firm
Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, corporate governance and shareholder rights, consumer, and cybersecurity and data privacy litigation, as well as whistleblower representation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at labaton.com.
Contacts
David J. Schwartz
(800) 321-0476
[email protected]
SOURCE: Labaton Sucharow LLP